HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Heart 2005;91:1257-1259; doi:10.1136/hrt.2004.056614
Copyright © 2005 BMJ Publishing Group Ltd & British Cardiovascular Society

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Read responses to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shavelle, D M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shavelle, D M

EDITORIAL

Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?

D M Shavelle

Correspondence to:
Correspondence to:
Dr David M Shavelle
Division of Cardiology, Harbor-UCLA Medical Center, Torrance, CA 90509, USA; dshavelle{at}hotmail.com


ABSTRACT
Angiotensin converting enzyme (ACE) inhibitors may become an accepted form of treatment for aortic stenosis in the future


Abbreviations: ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker; AS, aortic stenosis; LDL, low density lipoprotein; RAAS, renin–angiotensin–aldosterone system

Keywords: ACE inhibitors; angiotensin converting enzyme inhibitors; aortic stenosis; renin–angiotensin–aldosterone system




eLetters:

Read all eLetters

A proposal for eplerenone in aortic stenosis
Oscar, M Jolobe
Online, 3 Oct 2005 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 BMJ Publishing Group Ltd & British Cardiovascular Society